Sung H, Ferlay J, Siegel RL. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49. http://doi.org/10.3322/caac.21660

Bray F, Laversanne M, Sung H. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63. http://doi.org/10.3322/caac.21834

Morgan E, Arnold M. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72:338-44. http://doi.org/10.1136/gutjnl-2022-327736

Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology. 2010;138:2059-72. http://doi.org/10.1053/j.gastro.2009.12.06

Pettit C, Walston S, Wald P, Webb A, Williams TM. Molecular profiling of locally-advanced rectal adenocarcinoma using microRNA expression (Review). Int J Oncol. 2017;51:393-404. http://doi.org/10.3892/ijo.2017.4045

Imedio L, Cristóbal I, Rubio J, Santos A, Rojo F, García-Foncillas J. MicroRNAs in Rectal cancer: functional significance and promising therapeutic value. Cancers. 2020;12:2040. http://doi.org/10.3390/cancers12082040

He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522-31. http://doi.org/10.1038/nrg1379

Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. 2021;14:dmm047662. http://doi.org/10.1242/dmm.047662

Ardekani AM, Naeini MM. The role of microRNAs in human diseases. Avicenna J Med Biotechnol. 2010;2:161-79.

Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203-22. http://doi.org/10.1038/nrd.2016.246

De Palma FDE, Luglio G, Tropeano FP. The role of microRNAs and circulating tumor markers as predictors of response to neoadjuvant therapy in locally advanced rectal cancer. Int J Mol Sci. 2020;21:7040. http://doi.org/10.3390/ijms21197040

Fasano M, Pirozzi M, Miceli CC, Cocule M, Caraglia M. TGF-β modulated pathways in colorectal cancer: new potential therapeutic opportunities. Int J Mol Sci. 2024;25:7400. http://doi.org/10.3390/ijms25137400

Rosic J, Dragicevic S, Miladinov M, Despotovic J, Bogdanovic A, Krivokapic Z, Nikolic A. SMAD7 and SMAD4 expression in colorectal cancer progression and therapy response. Exp Mol Pathol. 2021;123:104714. http://doi.org/10.1016/j.yexmp.2021.104714

Despotovic J, Dragicevic S, Nikolic A. Effects of chemotherapy for metastatic colorectal cancer on the TGF-β signaling and related miRNAs hsa-miR-17-5p, hsa-miR-21-5p and hsa-miR-93-5p. Cell Biochem Biophys. 2021;79:757-67. http://doi.org/10.1007/s12013-021-00980-3

Li X, Zhang G, Luo F, Ruan J, Huang D, Feng D, Xiao D, Zeng Z, Chen X, Wu W. Identification of aberrantly expressed miRNAs in rectal cancer. Oncol Rep. 2012;28:77-84. http://doi.org/10.3892/or.2012.1769

Shen K, Cao Z, Zhu R, You L, Zhang T. The dual functional role of microRNA-18a (miR-18a) in cancer development. Clin Transl Med. 2019;8:32. http://doi.org/10.1186/s40169-019-0250-9

Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199-227. http://doi.org/10.1146/annurev.pathol.4.110807.092222

Gaedcke J, Grade M, Camps J, Søkilde R, Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi BM, Møller S, Beissbarth T, Ried T, Litman T. The rectal cancer microRNAome-microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res. 2012;18:4919-30. http://doi.org/10.1158/1078-0432.ccr-12-0016

Chang L, Zhou G, Soufan O, Xia J. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 2020;48:W244-w51. http://doi.org/10.1093/nar/gkaa467

Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G, Ollivier JM, Bonvalot S, Gignoux M. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73:2680-6. http://doi.org/10.1002/1097-0142(19940601)73:11<2680::aid-cncr2820731105>3.0.co;2-c

Millino C, Maretto I, Pacchioni B, Digito M, De Paoli A, Canzonieri V, D'Angelo E, Agostini M, Rizzolio F, Giordano A, Barina A, Rajendran S, Esposito G, Lanfranchi G, Nitti D, Pucciarelli S. Gene and microRNA expression are predictive of tumor response in rectal adenocarcinoma patients treated with preoperative chemoradiotherapy. J Cell Physiol. 2017;232:426-35. https://doi.org/10.1002/jcp.25441

Della Vittoria Scarpati G, Falcetta F, Carlomagno C, Ubezio P, Marchini S, De Stefano A, Singh VK, D'Incalci M, De Placido S, Pepe S. A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2012;83:1113-9. http://doi.org/10.1016/j.ijrobp.2011.09.030

Conde-Muiño R, Cano C, Sánchez-Martín V, Herrera A, Comino A, Medina PP, Palma P, Cuadros M. Preoperative chemoradiotherapy for rectal cancer: the sensitizer role of the association between miR-375 and c-Myc. Oncotarget. 2017;8:82294-302. http://doi.org/10.18632/oncotarget.19393

Nikolic A, Krivokapic Z. Nucleic acid-based markers of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Surg Oncol. 2022;41:101743. http://doi.org/10.1016/j.suronc.2022.101743

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 2008;113:57-64. http://doi.org/10.1002/cncr.23516

Wen B, Zhang L, Wang C, Huang R, Peng H, Zhang T, Dong J, Xiao W, Zeng Z, Liu M, Gao Y. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy. Radiat Oncol. 2015;10:124. http://doi.org/10.1186/s13014-015-0425-5

Stojkovic G, Jovanovic I, Dimitrijevic M, Jovanovic J, Tomanovic N, Stankovic A, Arsovic N, Boricic I, Zeljic K. Meta-signature guided investigation of miRNA candidates as potential biomarkers of oral cancer. Oral Dis. 2023;29:1550-64. http://doi.org/10.1111/odi.14185

Ourô S, Mourato C, Velho S, Cardador A, Ferreira MP, Albergaria D, Castro RE, Maio R, Rodrigues CMP. Potential of miR-21 to predict incomplete response to chemoradiotherapy in rectal adenocarcinoma. Front Oncol. 2020;10:577653. http://doi.org/10.3389/fonc.2020.577653

Badr D, Fouad MA, Hussein M, Salem S, Zekri A, Shouman S. Rebound increase in microRNA levels at the end of 5-FU-based therapy in colorectal cancer patients. Sci Rep. 2023;13:14237. http://doi.org/10.1038/s41598-023-41030-7

Chen X, Wu L, Li D, Xu Y, Zhang L, Niu K, Kong R, Gu J, Xu Z, Chen Z, Sun J. Radiosensitizing effects of miR-18a-5p on lung cancer stem-like cells via downregulating both ATM and HIF-1α. Cancer Med. 2018;7:3834-47. http://doi.org/10.1002/cam4.1527

Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Mol Carcinog. 2017;56:2669-80. http://doi.org/10.1002/mc.22710

Machackova T, Prochazka V, Kala Z, Slaby O. Translational potential of micrornas for preoperative staging and prediction of chemoradiotherapy response in rectal cancer. Cancers (Basel). 2019;11:1545. http://doi.org/10.3390/cancers11101545

Caramés C, Cristóbal I, Moreno V, del Puerto L, Moreno I, Rodriguez M, Marín JP, Correa AV, Hernández R, Zenzola V, Hernández T, León A, Martín JI, Sánchez-Fayos P, García-Olmo D, Rojo F, Goel A, Fernandez-Aceñero MJ, García-Foncillas J. MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer. Int J Colorectal Dis. 2015;30:899-906. http://doi.org/10.1007/s00384-015-2231-9

Svoboda M, Sana J, Fabian P, Kocakova I, Gombosova J, Nekvindova J, Radova L, Vyzula R, Slaby O. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. Radiat Oncol. 2012;7:195. http://doi.org/10.1186/1748-717x-7-195

Wada Y, Shimada M, Morine Y. Circulating miRNA signature predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer. JCO Precis Oncol. 2021;5:PO.21.00015. http://doi.org/10.1200/po.21.00015

Cristóbal I, Rubio J, Santos A, Torrejón B, Caramés C. MicroRNA-199b downregulation confers resistance to 5-fluorouracil treatment and predicts poor outcome and response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. Cancers. 2020;12:1655. http://doi.org/10.3390/cancers12061655

Lim SH, Chua W, Henderson C, Ng W, Shin JS, Chantrill L, Asghari R, Lee CS, Spring KJ, de Souza P. Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Crit Rev Oncol Hematol. 2015;96:67-80. http://doi.org/10.1016/j.critrevonc.2015.05.003

Losurdo P, Gandin I, Belgrano M, Fiorese I, Verardo R, Zanconati F, Cova MA, de Manzini N. microRNAs combined to radiomic features as a predictor of complete clinical response after neoadjuvant radio-chemotherapy for locally advanced rectal cancer: a preliminary study. Surg Endosc. 2023;37:3676-83. http://doi.org/10.1007/s00464-022-09851-1